Scientific paper - review paper
Current trends in the pharmacotherapy for obesity

Klobučar Majanović, Sanja; Crnčević Orlić, Željka; Štimac, Davor (2016)
Cite this document...

Klobučar Majanović, S., Crnčević Orlić, . & Štimac, D. (2016). Current trends in the pharmacotherapy for obesity. Endocrine Oncology and Metabolism, 2. (1), 50-59. doi: 10.21040/eom/2016.2.6

Klobučar Majanović, Sanja, et al. "Current trends in the pharmacotherapy for obesity." Endocrine Oncology and Metabolism, vol. 2, no. 1, 2016, pp. 50-59. https://doi.org/10.21040/eom/2016.2.6

Klobučar Majanović, Sanja, Željka Crnčević Orlić and Davor Štimac. "Current trends in the pharmacotherapy for obesity." Endocrine Oncology and Metabolism 2, no. 1 (2016): 50-59. https://doi.org/10.21040/eom/2016.2.6

Klobučar Majanović, S., Crnčević Orlić, . and Štimac, D. (2016) 'Current trends in the pharmacotherapy for obesity', Endocrine Oncology and Metabolism, 2(1), pp. 50-59. doi: 10.21040/eom/2016.2.6

Klobučar Majanović S, Crnčević Orlić , Štimac D. Current trends in the pharmacotherapy for obesity. Endocrine Oncology and Metabolism [Internet]. 2016 [cited 2019 August 25];2(1):50-59. doi: 10.21040/eom/2016.2.6

S. Klobučar Majanović, . Crnčević Orlić and D. Štimac, "Current trends in the pharmacotherapy for obesity", Endocrine Oncology and Metabolism, vol. 2, no. 1, pp. 50-59, 2016. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:359339. [Accessed: 25 August 2019]